Uterine Leiomyoma Treatment With Radiofrequency Ablation

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Uterine Fibroids
Interventions
PROCEDURE

Radiofrequency ablation of fibroids

The Acessa device delivers radiofrequency energy to uterine fibroids to destroy fibroid tissue. The patient undergoes a standard laparoscopy of the pelvis. A laparoscopic ultrasound is performed to identify the precise size and location of the fibroids. The Acessa radiofrequency probe is then placed into the fibroid and the radiofrequency energy is delivered. The fibroid tissue is destroyed and the fibroid shrinks down in size to decrease fibroid-related symptoms.

Trial Locations (5)

90024

University of California, Los Angeles, Los Angeles

94115

University of California, San Francisco, San Francisco

Unknown

University of California, Davis, Davis

University of California, Irivine, Irvine

University of California, San Diego, La Jolla

All Listed Sponsors
collaborator

University of California, Davis

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

University of California, San Diego

OTHER

lead

University of California, San Francisco

OTHER

NCT01840124 - Uterine Leiomyoma Treatment With Radiofrequency Ablation | Biotech Hunter | Biotech Hunter